Biotech · Private company
Navitor Pharmaceuticals, Inc.
Track this companyFree. Adds Navitor Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- NV-5138Phase 2 · Major Depressive DisorderClinicalTrials.gov · fetched Nov 12, 2026
- NV-5138Phase 2 · Treatment Resistant DepressionClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Open-Label of SPN-820 in Adults With Major Depressive DisorderPHASE2 · COMPLETED · started Feb 15, 2024ClinicalTrials.gov NCT06235905 · fetched Nov 12, 2026
- Phase 2 Study of NV-5138 in Adults With Treatment Resistant DepressionPHASE2 · COMPLETED · started Jan 18, 2022ClinicalTrials.gov NCT05066672 · fetched Nov 12, 2026
- Safety, Tolerability, PK and Efficacy of Single Doses of NV-5138 in Healthy Volunteers and Subjects With Treatment-Resistant DepressionPHASE1 · COMPLETED · started Jun 6, 2018ClinicalTrials.gov NCT03606395 · fetched Nov 12, 2026